Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis [NA]

View source ↗

Summary

Clinical trial evaluating therapeutic drug monitoring of Linezolid for rifampin-resistant tuberculosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis | NA | Status: RECRUITING